Fortress Biotech to Participate in October 2024 Investor Conferences

Company Overview - Fortress Biotech, Inc. is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings, and dividend and royalty revenue [2] - The company has seven marketed prescription pharmaceutical products and over 20 programs in development across six large-market areas, including oncology, rare diseases, and gene therapy [2] - Fortress operates a streamlined structure that fosters efficient drug development and leverages significant biopharmaceutical industry expertise and networks to expand its portfolio [2] Upcoming Events - Lindsay A. Rosenwald, M.D., Chairman, President, and CEO of Fortress, will participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024, at 4:15 p.m. ET, in a virtual format [1] - Fortress will also be present at the 3rd Annual ROTH Healthcare Opportunities Conference on October 9, 2024, in New York, focusing on 1x1 meetings [1] - A replay of the fireside chat from the Lytham Partners conference will be available on Fortress' website for approximately 30 days following the event [1]